Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05384119 |
| Title | Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Tvardi Therapeutics, Incorporated |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Holy Cross Health Fort Lauderdale - Holy Cross Hospital | Fort Lauderdale | Florida | 33308 | United States | Details | |
| Washington University School of Medicine Siteman Cancer Center | Saint Louis | Missouri | 63110 | United States | Details | |
| Vanderbilt - Ingram Cancer Center | Nashville | Tennessee | 37232 | United States | Details | |
| Texas Oncology - Dallas Fort Worth (DFW) - Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | United States | Details | |
| Harold C. Simmons Comprehensive Cancer Center | Dallas | Texas | 75390 | United States | Details | |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |